Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin‐2‐based immunotherapy

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer

• Publication date

  1992-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19920401)69:7<1850::AID-CNCR2820690729>3.0.CO;2-IPMID 1551067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relapse after response to interleukin-2-based immunotherapy: patterns of progression and response to retreatment.

  1991cited by this paper
• Thoracotomy for metastatic malignant melanoma of the lung.

  1990cited by this paper
• Salvage surgery for renal cell carcinoma.

  1989cited by this paper
• Experience with the Use of High‐Dose Interleukin‐2 in the Treatment of 652 Cancer Patients

  1989cited by this paper
• Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

  1989cited by this paper
• Resection of pulmonary metastases from malignant melanoma: results of a 16-year experience.

  1988cited by this paper
• Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

  1988cited by this paper
• A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

  1987cited by this paper
• Effect of surgical treatment on stage IV melanoma.

  1987cited by this paper
• Surgery as Palliative Treatment for Distant Metastases of Melanoma

  1986cited by this paper
• High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings.

  1986cited by this paper
• Metastatic melanoma to the lung: long-term results of surgical excision.

  1985cited by this paper
• Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

  1985cited by this paper
• Surgical treatment of distant metastatic melanoma indications and results

  1985cited by this paper
• Pulmonary resection of metastatic renal cell carcinoma.

  1983cited by this paper
• The natural history of resectable metastatic melanoma (Stage IVA Melanoma)

  1982cited by this paper
• Lung resection for metastatic melanoma.

  1980cited by this paper
• Surgical resection for metastatic neoplasms of the lung: Experience at the university of minnesota hospitals

  1980cited by this paper
• The contribution of surgery to the management of carcinomatous pulmonary metastases

  1978cited by this paper
• The treatment of renal cell carcinoma with solitary metastasis.

  1978cited by this paper
• Excision of Melanoma Metastases to Lung: Problems in Diagnosis and Management

  1973cited by this paper
• Diagnosis and management of renal cell carcinoma A clinical and pathologic study of 309 cases

  1971cited by this paper
• Surgery for metastatic renal cell carcinoma.

  1967cited by this paper

• Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis

  2020cites this paper
• Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach

  2017cites this paper
• Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma

  2016cites this paper
• Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma

  2016cites this paper
• Integration of Surgery in Metastatic Renal Cancer

  2013cites this paper
• Malignant Renal Tumors

  2012cites this paper
• Role of surgery for locally advanced and metastatic renal cell carcinoma.

  2011cites this paper
• Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience

  2011cites this paper
• Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.

  2011cites this paper
• Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

  2010cites this paper
• Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy

  2009cites this paper
• Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents

  2009cites this paper
• The contemporary role of surgery in kidney cancer

  2009cites this paper
• Role of cytoreductive nephrectomy in renal cell carcinoma.

  2009cites this paper
• [The role of surgery in bone metastases of renal cell carcinoma: 13 case reports].

  2008cites this paper
• More support for the judicious use of high-dose interleukin-2 in patients with advanced melanoma.

  2007cites this paper
• No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?

  2007cites this paper
• Original article No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma

  2007cites this paper
• The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy.

  2007cites this paper
• The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy

  2007cites this paper
• Metastasectomy plus immunotherapy compared with immunotherapy alone in metastatic renal cell carcinoma.

  2007cites this paper
• Treatment of oligometastases after successful immunotherapy.

  2006cites this paper
• Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.

  2006cites this paper
• Interferon alpha for the treatment of advanced renal cancer

  2005cites this paper
• Surgery for Metastases of Renal Cell Carcinoma

  2004cites this paper
• Changing concepts in the surgical management of renal cell carcinoma.

  2004cites this paper
• Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

  2000cites this paper
• Interleukin-2 in the treatment of renal cancer.

  2000cites this paper
• Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

  2000cites this paper
• Combined-modality Treatment of Renal Cell Carcinoma

  2000cites this paper
• [Treatment of metastatic renal cell carcinoma. Value of immunotherapy compared with surgery of metastases].

  2000cites this paper
• Immunotherapy: are we making a difference?

  2000cites this paper
• Surgical treatment of lung metastases: Prognostic factors for long‐term survival

  1999cites this paper
• Efficacy of multimodality therapy in advanced renal cell carcinoma.

  1998cites this paper
• Metachronous renal cell carcinoma metastases to spermatic cord and penis.

  1997cites this paper
• Surgical resection of metastatic renal cell carcinoma: The University of Iowa experience.

  1997cites this paper
• Immuntherapie des metastasierten Nierenzellkarzinoms Ist der klinische Einsatz in Anbetracht der Ergebnisse, Nebenwirkungen und Kosten gerechtfertigt?

  1997cites this paper
• [Surgical treatment of metastases in renal cell carcinoma].

  1997cites this paper
• [Immunotherapy of metastatic renal cell carcinoma. Is clinical use justified in view of outcome, side effects and costs?].

  1997cites this paper
• Surgical treatment of metastases in patients with renal cell carcinoma

  1997cites this paper
• Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery.

  1996cites this paper
• Therapy of locally recurrent renal cell carcinoma after nephrectomy.

  1996cites this paper
• Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.

  1996cites this paper
• Nephron sparing surgery in patients with metastatic renal cell carcinoma.

  1996cites this paper
• Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions.

  1994cites this paper
• The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma.

  1994cites this paper
• Pediatric renal cell carcinoma: a complete response to recombinant interleukin-2 in a child with metastatic disease at diagnosis.

  1994cites this paper
• Surgical management of recurrent genitourinary malignancies.

  1993cites this paper
• Multimodale Therapie des metastasierenden malignen Melanoms: Resektion residualen Tumors nach Immuntherapie mit Interleukin-2 und Interferon-α

  1993cites this paper
• [Preoperative grading of renal cell carcinoma by plasma immunosuppressive acidic protein level and tumor diameter using discriminant analysis].

  1993cites this paper
• The management of isolated renal recurrence of renal cell carcinoma following complete response to interleukin-2 based immunotherapy.

  1993cites this paper
• U R O L O G I C O N C O L O G Y the Contemporary Role of Surgery in Kidney Cancer 2. Surgical Treatment for Localized Rcc 2.1 Radical Nephrectomy

  year unknowncites this paper